Myocardical Infarction in Young Adults: Revisiting Risk Factors and Atherothrombotic Pathways

Petre Alexandru Cojocaru1, Maria Loredana Țieranu2, Mina Teodora Luminița Piorescu3,4

  • 1Department of Cardiology, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania.

Medicina (Kaunas, Lithuania)
|September 27, 2025
PubMed

Insights

Myocardial infarction (MI) in young adults is a growing concern, often lacking traditional risk factors. This review explores unique causes and diagnostic challenges in younger patients.

Area of Science:

  • Cardiology
  • Internal Medicine
  • Preventive Medicine

Background:

  • Myocardial infarction (MI) in young adults is an emerging clinical issue.
  • Younger patients often lack traditional cardiovascular risk factors and advanced atherosclerosis.
  • This necessitates reevaluation of MI pathophysiology and risk assessment in this demographic.

Purpose of the Study:

  • To review the epidemiology, pathophysiology, and diagnostic challenges of MI in adults under 55.
  • To differentiate between traditional and emerging risk factors for MI in young adults.
  • To highlight non-atherosclerotic mechanisms contributing to MI in this population.

Main Methods:

  • Narrative literature review focusing on studies from the last five years.
  • Inclusion of data from large registries, cohort studies, and experimental findings.
  • Emphasis on MI in young adults (under 55 years).

Main Results:

  • Young adults with MI present with diverse risk factor profiles, including traditional and emerging factors.
  • Emerging contributors include elevated lipoprotein(a), recreational drug use, autoimmune conditions, and psychosocial stress.
  • Non-atherosclerotic mechanisms like spontaneous coronary artery dissection (SCAD) and Takotsubo syndrome are relevant.

Conclusions:

  • MI in young adults is a distinct entity requiring tailored diagnostic and management strategies.
  • Understanding unique risk factors and pathophysiologies is crucial for effective prevention and treatment.
  • Further research is needed to refine risk assessment and therapeutic approaches for this population.

Related Concept Videos

Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
374
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
3.0K
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
361
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
321
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
923
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
882